Literature DB >> 11049128

A European multicentric experience using the CardioSEal and Starflex double umbrella devices to close interatrial communications holes within the oval fossa.

M Carminati1, S Giusti, G Hausdorf, S Qureshi, M Tynan, M Witsenburg, J Hess, J F Piechaud, P Bonhoeffer, A Donti, C Ovaert, H Sievert, N Elzenga, M Talsma, A van Oort, J Ernst, M Gewillig, B De Geeter.   

Abstract

In this review, we describe the experience from 13 European centres using the CardioSEAL and Starflex double umbrella devices to close interatrial communications within the oval fossa (so-called 'secundum' defects). Between October 1996 and April 1999, the procedure was attempted in 334 patients with a mean age of 12 years and a mean weight of 44kg. The mean measured stretched diameter of the defect was 15 mm. In the overall group, the defect was solitary in 245 patients (73%), multiple in 21 (6%), associated with an aneurysm of the flap valve in 15 (5 %), was represented by patency of the oval foramen in 44 (13%), and was a fenestration in a Fontan repair in 9 (3%). In all patients, the devices were inserted under general anesthesia, using fluoroscopic and transesophageal echocardiographic control. Implantation was achieved in 325 (97,3%). The device embolized within either a few minutes or a few hours in 13 patients (4%). Of these, uncomplicated surgical repair was undertaken in 10, while the device was retrieved in 3 using catheters and a second device was successfully implanted. Residual shunting was detected immediately after the procedure in 41% of the patients, with the incidence decreasing to 31% at discharge, 24% at 1 month, 21% at 6 months, and 20.5% at one year. During the period of follow-up, elective surgical repair became necessary in two patients, due to malposition of the device in one, and late embolization in the other. Fractures of arms were seen in 6.1 %, most commonly with the largest devices. All those with fractured arms of the device were asymptomatic, and no clinical complications related to the fractures were observed. There were no arrhythmias, endocarditis, valvar distortion, thromboembolic events, or other complications. After one year of follow-up, clinical success, defined as complete closure of the defect or presence of only a trivial leak, had been obtained in 92.5% of the patients. We conclude, therefore, that these devices produce excellent results when used to close defects of small to moderate size. Results are less than optimal, or else complications ensure, when attempts are made to close very large defects.

Entities:  

Mesh:

Year:  2000        PMID: 11049128     DOI: 10.1017/s1047951100008210

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  12 in total

1.  Use of the transseptal puncture in transcatheter closure of long tunnel-type patent foramen ovale.

Authors:  C J McMahon; H G El Said; C E Mullins
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

Review 2.  Closing down: transcatheter closure of intracardiac defects and vessel embolisations.

Authors:  Jean-François Piéchaud
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

Review 3.  Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-06-23       Impact factor: 1.731

4.  A novel implantation technique for closure of an atypical fenestration connecting the right atrial appendage to an extracardiac conduit by use of a 15 mm Helex device in a patient with total cavopulmonary connection.

Authors:  M Peuster; P Beerbaum
Journal:  Z Kardiol       Date:  2004-10

Review 5.  Embolization and transcatheter retrieval of coils and devices.

Authors:  C A Tan; D S Levi; J W Moore
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

Review 6.  Catheter interventions in adult patients with congenital heart disease.

Authors:  Timothy S Hornung; Lee N Benson; Peter R McLaughlin
Journal:  Curr Cardiol Rep       Date:  2002-01       Impact factor: 2.931

Review 7.  Interventional cardiac catheterisation in congenital heart disease.

Authors:  R E Andrews; R M R Tulloh
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

8.  Cribriform amplatzer device closure of fenestrated atrial septal defects: feasibility and technical aspects.

Authors:  Mohammed Numan; Amal El Sisi; Magdi Tofeig; Salwa Gendi; Tohami Tohami; Howaida G El-Said
Journal:  Pediatr Cardiol       Date:  2007-11-13       Impact factor: 1.655

9.  Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients.

Authors:  G Fischer; J Stieh; A Uebing; U Hoffmann; G Morf; H H Kramer
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

10.  The gold standard for atrial septal defect closure: current surgical results, with an emphasis on morbidity.

Authors:  R J F Baskett; E Tancock; D B Ross
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.